Dow AgroSciences to market NRC technologies

Guest Contributor
December 1, 2003

Dow AgroSciences, Indianapolis IN, will market antibody technologies developed under a 2001 collaboration agreement between its Canadian subsidiary and the National Research Council’s Institute for Biological Sciences. The licence agreement will see the technologies used to reduce the risk of food-borne pathogens by attacking them at the source without the use of traditional antibiotics. FMI: www.dowagro.com/ca....


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.